Abbvie Inc. vs Baxter International Inc.
ABBV vs BAX — side-by-side comparison from reported financials. ABBV leads 10, BAX leads 1 of 11 comparable metrics.
Abbvie Inc.
ABBV · Healthcare
$276.43+1.47%Mixed
Baxter International Inc.
BAX · Healthcare
$24.35+1.88%Mixed
| Metric | ABBV | BAX |
|---|---|---|
| Price | $276.43 | $24.35 |
| Market cap | $488B | $12.6B |
| Revenue (TTM) | $64.4B | $11.5B |
| Revenue growth | +1.8% | -9.4% |
| Net margin | 9.8% | -9.3% |
| Free cash flow | $18.2B | $931M |
| Net cash (debt) | ($56.2B) | $1.97B |
| 1-year price return | +19.8% | +8.2% |
| P/E | 77.4 | — |
| P/E vs own history (cheap-side %) | 23% | 9% |
| Dividend yield | 2.45% | 1.46% |
| Return on equity | 96% | -17% |
| Altman Z-score | 2.33 | 2.12 |
| CV checks passed | 9 of 11 | 8 of 11 |
| Employees | 57,000 | 37,500 |
Full résumé-style profiles: ABBV CV · BAX CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.